Less than four months after spinning out of Vancouver’s Terramerra, agtech startup Catalera BioSolutions has announced the initial close of its Series A funding round.
The USD $8M investment round was led by S2G Ventures, with follow-up investment from Farm Credit Canada (FCC) Capital, and a second and final close expected in Q4 of 2024.
Catalera is a pioneering innovator in biological pest control solutions that uses a purpose-built toolkit of patented technologies.
Building on a solid foundation from existing commercial products including: RANGO® for specialty crops, SOCORO® for row crops, Vaporpad® for professional bed bug treatment and the recent registration of TRIFECTO® in Mexico, the company is well positioned to deploy several new biological products over the next few years and substantially grow its portfolio.
The $70 billion synthetic chemistry industry for agriculture and consumer pest control is facing significant challenges stemming from nearly a century of over reliance on synthetic chemicals. This has created far-reaching impacts in the world including food security risks, soil and water damage, and negative effects on human health.
“Consumers, government, and industry, including the world’s largest agriculture companies, are wanting to move to biologicals. But natural solutions need a helping hand to meet the needs of industry, growers, and consumers. As an experienced and agile company, Catalera holds the keys to unlocking the potential of biologicals and making a major impact in agriculture and beyond,” said Matthew Dahabieh, CEO of Catalera.
“Our team has been developing safe, effective, and cost-competitive biological products for over a decade. We have launched numerous products with leading partners, and have an exciting pipeline of new products in development, which this new funding will help us get to market.”
Leave a Reply